ASC47,an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity,demonstrated a half-life of up to 26 days and 40 days,respectively,in Phase Ib single subcutaneous i
BEIJING,March 8,2025-- A news report fromchinadaily.com.cn： The intensified multilateral and bilateral exchanges between China and other countries and regions have led to an increase in foreign-relat
SEOUL,South Korea,March 10,2025-- HD Hyundai Executive Vice Chairman Chung Kisun met with Palantir Technologies Inc. CEO Alex Karp to discuss the project on building AI shipyards.
HONG KONG,March 10,2025-- On March 5,during the 2025 Mobile World Congress (MWC25),the 5GUAV medical delivery network solution jointly developed by China Telecom,Hangzhou Antwork Network Technology an
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar
SYDNEY,March 10,2025-- HKA,a leading global consultancy in risk mitigation and dispute resolution,is excited to announce that Jacqueline Woods has joined its rapidly expanding Forensic Accounting and
